Home β€Ί Stock analysis β€Ί EDVA

Endovia Health Sciences (EDVA) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET

Updated Oct 15, 2026, 4:00 PM ET

What changed since yesterday

EDVA jumps 5.0% to $0.15. Closed at $0.15, +5.00% vs the prior close of $0.14. Day range $0.13–$0.15, opened at $0.14.

Last close$0.15+5.00%
Day range0.13–0.15
Open0.14
Volume283.70K
52-week range0.13–13.40
Avg volume (20d)7.17M

EDVA daily analysis β€” what happened

A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.

Oct 15, 2026 β€” EDVA jumps 5.0% to $0.15
Oct 14, 2026 β€” EDVA dips 0.7% to $0.14, a 52-week low, 6 down days in a row
Oct 13, 2026 β€” EDVA slides 3.4% to $0.14, a 52-week low, 5 down days in a row
Oct 12, 2026 β€” EDVA slides 6.4% to $0.15, a 52-week low, 4 down days in a row
Oct 9, 2026 β€” EDVA dips 2.5% to $0.16, a 52-week low, 3 down days in a row
Oct 8, 2026 β€” EDVA slides 3.0% to $0.16
Oct 7, 2026 β€” EDVA dips 1.8% to $0.17
Oct 6, 2026 β€” EDVA rises 1.2% to $0.17
Oct 5, 2026 β€” EDVA jumps 4.4% to $0.17
Oct 2, 2026 β€” EDVA dips 1.2% to $0.16, a 52-week low, 5 down days in a row

EDVA latest news & SEC filings

Every SEC filing by or about EDVA in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Oct 15, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001731122-26-001347

Oct 8, 2026 Β· Form DEFA14A β€” Additional proxy materials

Additional proxy materials

Source: SEC EDGAR filing 0001731122-26-001326

Oct 6, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001731122-26-001320

Oct 5, 2026 Β· Form DEF 14A β€” Proxy statement

Proxy statement β€” agenda for the shareholder meeting (board elections, executive pay, votes)

Source: SEC EDGAR filing 0001731122-26-001316

Oct 5, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001731122-26-001312

Sep 24, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001731122-26-001281

Sep 23, 2026 Β· Form PRE 14A β€” Preliminary proxy statement

Preliminary proxy statement

Source: SEC EDGAR filing 0001731122-26-001276

Sep 22, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001731122-26-001271

Sep 18, 2026 Β· Form PRE 14A β€” Preliminary proxy statement

Preliminary proxy statement

Source: SEC EDGAR filing 0001731122-26-001262

Aug 31, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001731122-26-001173

Aug 28, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001731122-26-001170

Aug 28, 2026 Β· Form 424B3 β€” Prospectus / supplement for an offering or resale

Prospectus / supplement for an offering or resale

An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.

Source: SEC EDGAR filing 0001731122-26-001169

Aug 26, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001731122-26-001152

Aug 25, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001731122-26-001144

Aug 24, 2026 Β· Form EFFECT β€” EFFECT filing

EFFECT filing

Source: SEC EDGAR filing 9999999995-26-002743

Things to know before you trade EDVA

EDVA market data (last 20 sessions)

DateOpenHighLowCloseVolume
Oct 15, 20260.140.150.130.15283.70K
Oct 14, 20260.140.150.140.14249.20K
Oct 13, 20260.160.160.140.14193.40K
Oct 12, 20260.150.150.140.15286.60K
Oct 9, 20260.160.160.150.16293.10K
Oct 8, 20260.160.170.150.16315.80K
Oct 7, 20260.170.170.160.17214.00K
Oct 6, 20260.160.170.150.17773.60K
Oct 5, 20260.170.180.160.179.04M
Oct 2, 20260.160.160.150.16414.00K
Oct 1, 20260.170.170.160.16477.20K
Sep 30, 20260.170.180.170.18455.20K
Sep 29, 20260.180.180.160.18994.10K
Sep 28, 20260.190.190.170.191.08M
Sep 25, 20260.190.200.180.191.55M
Sep 24, 20260.190.200.170.194.00M
Sep 23, 20260.250.310.170.2066.59M
Sep 22, 20260.240.250.230.2354.37M
Sep 21, 20260.250.260.230.24709.30K
Sep 18, 20260.260.290.250.251.11M

About Endovia Health Sciences

Endovia Health Sciences (EDVA) is listed on the NYSE and classified by the SEC under β€œBeverages”. Its business address is in FORT LAUDERDALE, FL. State of incorporation: NV. Fiscal year ends December 31. SEC CIK 1553788.

EDVA board of directors & executives

From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).

Directors

NameRoleLatest filing
Frederick William CapleDirectorJun 10, 2026
Brady James CobbInterim CEOJun 10, 2026
Thomas Butler ForeDirectorJun 10, 2026
Knuettel Ii FrancisDirectorJun 10, 2026
Robert NisticoCEO and ChairmanOct 15, 2025
Justin W YorkeDirectorOct 15, 2025

Executive officers

NameTitleLatest filing
Michael Breen BondurantChief Operating OfficerJun 18, 2026
Brady James CobbInterim CEOJun 10, 2026
William T DevereuxChief Financial OfficerOct 15, 2025
William R. MeissnerPresident and CMOOct 14, 2025
Robert NisticoCEO and ChairmanOct 15, 2025
Martin P ScottInterim CFOJun 10, 2026

Recent insider buys & sales

DateInsiderTypeSharesPrice
No open-market insider buys or sales reported in the last 12 months.

EDVA financials (annual, from XBRL filings)

Fiscal year endRevenueNet incomeDiluted EPSOperating cash flow
Dec 31, 2025$73.07K$-25.23M-11.97$-4.82M
Dec 31, 2024$801.27K$-23.76M-17.68$-7.30M
Dec 31, 2023$18.85M$-21.00Mβ€”$-10.19M
Dec 31, 2022$18.09M$-21.69Mβ€”$-14.04M
Dec 31, 2021$11.32M$-29.05M-1.02$-14.70M

Latest balance sheet: total assets $1.08M, total liabilities $16.83M, cash $242.70K (as of Jun 30, 2026).

EDVA earnings / results-day log

DateFilingClose that day
Aug 20, 20268-K Item 2.02 (results)$0.43
Aug 16, 20238-K Item 2.02 (results)β€”
Nov 17, 20228-K Item 2.02 (results)β€”
Aug 16, 20228-K Item 2.02 (results)β€”
May 17, 20228-K Item 2.02 (results)β€”
Apr 1, 20228-K Item 2.02 (results)β€”
Nov 17, 20218-K Item 2.02 (results)β€”
Aug 18, 20218-K Item 2.02 (results)β€”
May 14, 20218-K Item 2.02 (results)β€”
Nov 17, 20208-K Item 2.02 (results)β€”
Aug 18, 20208-K Item 2.02 (results)β€”

Related stocks Β· Beverages

Coca-Cola (KO)PepsiCo (PEP)Keurig Dr Pepper (KDP)Constellation Brands (STZ)Diageo (DEO)Primo Brands (PRMB)Brown Forman (BF-B)Ambev (ABEV)Vita Coco (COCO)Suja Life (SUJA)

Popular today

Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)Space Exploration Technologies (SPCX)AMD (AMD)Apple (AAPL)Tesla (TSLA)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)

More on EDVA

Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.